A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants
A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants is a paper indexed in ScholarIQ from OpenAlex.
How many citations does A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants have?
A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants has 361 citations in the OpenAlex counts ScholarIQ stores.
When was A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants published?
A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants has 2017 year in the ScholarIQ index.
What is the open-access status of A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants?
A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants has closed oa status in the ScholarIQ index.
What is the DOI of A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants?
The DOI for A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants is on the source record.
What is the PMID of A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants?
The PMID for A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants is on the source record.
What is the OpenAlex record for A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants?
The OpenAlex for A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants is on the source record.